Target intelligence / Profile preview

MHC class I polypeptide-related sequence G (pseudogene) (MICG)

Target: MICG
Molecular classification: Other, Pseudogene, Related to MHC class I family (by sequence homology, not function)

Overview

MHC class I polypeptide-related sequence G (MICG) is a human pseudogene located on chromosome 6, annotated under several databases (e.g., Ensembl, HGNC). Unlike functional MHC class I-related proteins such as MICA and MICB, which act as stress ligands for immune activation, the MICG gene does not encode a functional protein and has no known expression, function, or disease relevance[2][3][5][6]. As such, MICG is not considered or used as a therapeutic target.

Other names: MICGMHC class I chain-related gene G pseudogeneOther nomenclature variants referencing its status as a pseudogene

Beyond the preview

Go deeper on MHC class I polypeptide-related sequence G (pseudogene) (MICG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MHC class I polypeptide-related sequence G (pseudogene) (MICG).

Explore the full profile